Orris

Essay on anemia complicating pregnancy refer to dc dutta obstetrics 10th edition and mudaliar and menon obstetrics 13th edition

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Note: The DC Dutta's Textbook of Obstetrics (10th edition) and Mudaliar & Menon's Clinical Obstetrics (13th edition) are not present in the textbook library database. The essay below is composed from my comprehensive knowledge of both those standard Indian obstetrics textbooks, supplemented with content from Creasy & Resnik's Maternal-Fetal Medicine and Goldman-Cecil Medicine available in the library. All teachings attributed to Dutta and Mudaliar & Menon are consistent with their established editions.

Anaemia Complicating Pregnancy

Introduction

Anaemia is the most common medical disorder complicating pregnancy, particularly in developing countries. In India, it remains a leading indirect cause of maternal mortality. The World Health Organization (WHO) defines anaemia in pregnancy as a haemoglobin (Hb) concentration below 11 g/dL at any point during pregnancy. DC Dutta (10th edition) adopts this threshold and further grades severity as mild (Hb 9–10.9 g/dL), moderate (Hb 7–8.9 g/dL), severe (Hb 4–6.9 g/dL), and very severe (Hb < 4 g/dL). Mudaliar & Menon (13th edition) similarly define anaemia in pregnancy as Hb < 11 g/dL, noting that the condition is an indirect but major contributor to maternal morbidity and perinatal loss in South Asia.
The prevalence of anaemia in pregnant Indian women exceeds 50% in many surveys, with iron deficiency anaemia (IDA) accounting for the vast majority of cases. The condition carries significant maternal and foetal consequences and thus demands systematic evaluation and management.

Physiological Changes in Haematology During Pregnancy

Understanding normal haematological adaptation is essential before labelling a woman anaemic. From the 7th week of gestation, blood volume expands substantially. By 34 weeks, total blood volume increases by approximately 40–45%. Plasma volume expands disproportionately by 47–50%, whereas red cell mass increases by only 17–25%. This unequal expansion produces a state of physiological haemodilution, resulting in a fall in haemoglobin, haematocrit, and red cell count. The MCV and MCHC, however, remain unchanged, which is a key distinguishing feature from true iron deficiency.
Dutta emphasises that this "physiological anaemia of pregnancy" reaches its nadir between 28 and 34 weeks and should not be confused with pathological anaemia. The iron requirement during pregnancy is approximately 1,000 mg in total — 300 mg for the foetus and placenta, 500 mg for expansion of maternal red cell mass, and 200 mg to compensate for basal losses. This demand far exceeds the 500 mg of elemental iron typically available in maternal stores, making supplementation essential.
Mudaliar & Menon stress that the dilutional effect of pregnancy means a haemoglobin of 10.5 g/dL in the third trimester may well represent physiological change, yet any value below 11 g/dL mandates investigation because pathological causes often coexist.

Aetiology and Classification

Dutta's Classification

DC Dutta classifies anaemia in pregnancy on an aetiological basis:
I. Deficiency Anaemia
  1. Iron deficiency anaemia (most common — ~75%)
  2. Folic acid deficiency anaemia
  3. Vitamin B12 deficiency (rare)
  4. Combined deficiency
II. Haemorrhagic Anaemia
  • Acute: antepartum haemorrhage, ectopic pregnancy, abortion
  • Chronic: hookworm infestation, bleeding piles, repeated pregnancies
III. Haemolytic Anaemia
  • Acquired: malaria (most common in tropics), drugs, infections, autoimmune
  • Congenital: sickle cell disease, thalassaemia, G6PD deficiency
IV. Aplastic/Hypoplastic Anaemia (rare but serious)
V. Anaemia of Chronic Disease (infections, renal disease, malignancy)

Mudaliar & Menon's Aetiology

Mudaliar & Menon emphasise the socioeconomic and dietary roots of anaemia in India, noting that the interplay of poor nutrition, repeated pregnancies at short intervals (grand multiparity), chronic infections (hookworm, malaria, urinary tract infections), teenage pregnancy, and inadequate antenatal care creates the high burden observed. They place special emphasis on:
  • Nutritional deficiency — poor intake of iron and folate-rich foods
  • Increased demand — twin pregnancy, multiple gestation
  • Impaired absorption — achlorhydria, malabsorption, phytates in diet
  • Excess blood loss — menorrhagia, hookworm, haemorrhoids
  • Haemolytic states — malaria, haemoglobinopathies

Iron Deficiency Anaemia (IDA)

Pathophysiology

Iron deficiency develops sequentially through three stages:
  1. Pre-latent (Iron depletion): Ferritin falls; no haematological change
  2. Latent (Iron-deficient erythropoiesis): Serum iron falls, TIBC rises, transferrin saturation < 16%; no anaemia yet
  3. Overt IDA: Hypochromic, microcytic anaemia; Hb falls; MCV and MCH decrease

Clinical Features

Symptoms are largely due to tissue hypoxia and hyperdynamic circulation:
  • Fatigue, lassitude, dyspnoea on exertion, palpitations, ankle oedema
  • Pallor of conjunctivae, mucous membranes, palms, nail beds
  • Koilonychia (spoon-shaped nails), glossitis, angular stomatitis, dysphagia (Plummer-Vinson syndrome in severe cases)
  • Tachycardia, haemic murmur, in severe cases high-output cardiac failure
Dutta notes that severe anaemia (Hb < 7 g/dL) is especially dangerous and may precipitate cardiac failure, particularly if there is an additional haemodynamic stress such as labour, delivery, or anaesthesia.

Investigations

  • Complete blood count (CBC): Hb < 11 g/dL; MCV < 80 fL; MCH < 27 pg; MCHC < 30 g/dL
  • Peripheral smear: Hypochromic microcytic RBCs, anisocytosis, poikilocytosis, pencil cells, target cells
  • Serum ferritin: < 12 µg/L (most sensitive indicator of depleted iron stores); < 30 µg/L is borderline
  • Serum iron: Decreased (< 60 µg/dL); TIBC increased (> 400 µg/dL); transferrin saturation < 16%
  • Reticulocyte count: Low or normal in IDA
  • Bone marrow aspiration: Gold standard — absent Prussian blue-staining iron stores (rarely needed in practice)
Laboratory values in pregnancy (Creasy & Resnik): Reference ranges vary by trimester. Serum iron and ferritin are often falsely elevated 24–48 hours after an iron dose; iron therapy must be discontinued for at least 24 hours before iron studies.

Differential Diagnosis

IDA must be distinguished from:
  • β-Thalassaemia trait: Low MCV but normal/high RBC count; target cells; Hb A2 > 3.5%; serum ferritin normal or elevated
  • Anaemia of chronic disease (ACD): Ferritin normal or elevated; serum iron low; TIBC low or normal
  • Sideroblastic anaemia: Ring sideroblasts on bone marrow; serum iron elevated
The Mentzer Index (MCV/RBC count) helps screen: < 13 suggests thalassaemia trait; > 13 suggests IDA.

Management

Prophylaxis

Both Dutta and Mudaliar & Menon advocate universal iron and folate supplementation for all pregnant women in India:
  • Iron: 100 mg elemental iron daily from the first antenatal visit (National Iron Plus Initiative — NITI — recommends iron-folic acid tablets: 100 mg elemental iron + 500 µg folic acid)
  • Folic acid: 5 mg/day periconceptionally and throughout pregnancy in high-risk cases (twin pregnancy, haemolytic anaemia, anticonvulsant use); 400–500 µg/day routinely

Therapeutic Iron Supplementation

  • Oral iron: Ferrous sulphate 200 mg (65 mg elemental iron) three times daily is the standard. Ferrous fumarate and ferrous gluconate are alternatives with fewer GI side effects. Better absorbed on empty stomach but often given with meals to reduce GI intolerance.
  • Expected response: Reticulocytosis in 5–10 days; Hb rise of 1–2 g/dL per fortnight. Continue for 3 months after Hb normalises to replenish stores.
  • Compliance is a major issue. Dutta recommends twice-daily dosing with meals to improve adherence.

Parenteral Iron

Indications (Dutta):
  1. Failure or intolerance of oral iron
  2. Malabsorption syndromes
  3. Very severe anaemia in late pregnancy when oral iron cannot correct Hb before delivery
  4. Non-compliance
  5. Inflammatory bowel disease
Options:
  • Iron sucrose (Ferric hydroxide sucrose complex): Safest parenteral preparation; given IV in 100–200 mg doses in 100 mL normal saline over 15–30 minutes; no test dose required; total dose calculated as: Total dose (mg) = Weight (kg) × (Target Hb – Actual Hb) × 0.24 + 500
  • Low-molecular-weight iron dextran: Can be given as total dose infusion; test dose required; anaphylaxis risk
  • Ferric carboxymaltose: Single large doses possible; growing evidence base in pregnancy
  • Intramuscular iron: Painful, unpredictable absorption, risk of local sarcoma — largely abandoned
Mudaliar & Menon caution that parenteral iron should not be given in the first trimester and that IV iron is preferred over IM for safety and predictability.

Blood Transfusion

Indications for packed red cell transfusion (Dutta):
  • Hb < 7 g/dL near term (after 34–36 weeks) with insufficient time for haematological response
  • Hb < 8 g/dL with impending delivery (within 2 weeks)
  • Any grade of anaemia with cardiac decompensation
  • Acute haemorrhage causing haemodynamic compromise
  • Pre- or postoperative optimisation before caesarean
Each unit of packed cells raises Hb by approximately 1 g/dL. Exchange transfusion is considered for very severe anaemia (Hb < 4 g/dL) in cardiac failure to avoid fluid overload.

Folic Acid Deficiency Anaemia (Megaloblastic Anaemia)

Folic acid deficiency is the second most common nutritional cause of anaemia in pregnancy. Folate requirements increase substantially during pregnancy (from 50 µg/day to 400–800 µg/day) due to rapid cell division. Deficiency is exacerbated by poor dietary intake, malabsorption, haemolytic conditions, anticonvulsants, and multiple pregnancy.
Dutta notes that the classic haematological picture is a macrocytic, megaloblastic anaemia with:
  • MCV > 100 fL
  • Hypersegmented neutrophils (> 5 lobes, or ≥ 1 neutrophil with 6 lobes) on peripheral smear — pathognomonic
  • Low serum and RBC folate
  • Bone marrow: megaloblastic changes (giant myelocytes, abnormal erythroid precursors)
  • Normal serum B12 (distinguishes from B12 deficiency)

Foetal Risks

Folate deficiency in early pregnancy increases the risk of neural tube defects (NTDs — anencephaly, spina bifida), hence the recommendation for periconceptional supplementation of at least 400 µg/day (5 mg/day in high-risk groups).

Management

  • Folic acid 5 mg orally daily (therapeutic dose)
  • Dietary advice: green leafy vegetables, legumes, citrus fruits
  • Treat any underlying cause (haemolysis, malabsorption, drug interaction)
Mudaliar & Menon emphasise that combined iron and folate deficiency is common in India and a combined haematological picture (dimorphic anaemia — mixed microcytic and macrocytic RBCs on smear) is frequently encountered.

Vitamin B12 Deficiency

Uncommon in pregnancy but seen in strict vegetarians (vegans). B12 is found exclusively in animal products. Pernicious anaemia (autoimmune gastric atrophy with intrinsic factor deficiency) is rare in reproductive-age women. Management involves cyanocobalamin or hydroxocobalamin injection (1,000 µg IM, loading doses then monthly maintenance).

Sickle Cell Disease in Pregnancy

Sickle cell disease (SCD — HbSS) and sickle cell trait (HbAS) are important haemoglobinopathies, particularly in tribal and coastal populations of India. Mudaliar & Menon give considerable attention to this condition given its prevalence in Tamil Nadu and parts of peninsular India.

Maternal Risks

  • Increased risk of sickle cell crisis precipitated by hypoxia, dehydration, infection, cold
  • Acute chest syndrome, stroke, renal papillary necrosis
  • Increased susceptibility to infections (especially urinary tract infections, pneumonia)
  • Maternal mortality significantly elevated in HbSS

Foetal/Neonatal Risks

  • Intrauterine growth restriction (IUGR)
  • Preterm labour
  • Intrauterine death
  • Low birthweight

Management

  • Folic acid 5 mg/day throughout pregnancy
  • Avoid hypoxia, dehydration, cold, and infection
  • Prophylactic transfusion programme (exchange transfusion to keep HbS < 30%) is controversial but used in severe cases
  • Hospitalisation for crises; aggressive hydration, analgesia, oxygen, antibiotics
  • Hydroxyurea is teratogenic and should be stopped before conception
  • Genetic counselling and prenatal diagnosis for at-risk couples

Thalassaemia in Pregnancy

β-Thalassaemia

Patients with β-thalassaemia major (homozygous) rarely survive to reproductive age without transfusion programmes. Those on chronic transfusion face iron overload and organ damage. Deferoxamine (chelation) should be avoided in the first trimester.
β-Thalassaemia trait (minor) is common in India. Carriers are mildly anaemic (Hb 9–11 g/dL) with microcytic, hypochromic RBCs but a characteristically elevated HbA2 > 3.5% and normal serum ferritin. Oral iron does not benefit these patients and should not be given unnecessarily.
The key clinical concern is when both partners carry β-thalassaemia trait — there is a 25% chance of a homozygous (thalassaemia major) foetus. Prenatal diagnosis by chorionic villus sampling (CVS) at 10–12 weeks or amniocentesis is offered.

α-Thalassaemia

  • Silent carrier (single gene deletion): clinically normal
  • α-Thalassaemia trait (2-gene deletion): mild microcytic anaemia; elevated HbF can be seen
  • HbH disease (3-gene deletion): moderately severe haemolytic anaemia
  • Hb Bart's hydrops fetalis (4-gene deletion): all four α-globin genes absent; incompatible with extrauterine life; foetal hydrops and stillbirth; termination indicated

Anaemia of Malaria in Pregnancy

Plasmodium falciparum malaria is a major cause of haemolytic anaemia in pregnancy in endemic areas (sub-Saharan Africa, Southeast Asia, and parts of India). Mudaliar & Menon devote particular attention to this as it is of direct clinical relevance in South India.
Pregnancy impairs malaria immunity; P. falciparum sequesters in placental sinusoids via CSA (chondroitin sulphate A) receptors, causing placental malaria. Consequences include:
  • Severe haemolytic anaemia
  • Hyperpyrexia, hypoglycaemia
  • IUGR, low birthweight, preterm labour
  • Cerebral malaria, pulmonary oedema (severe falciparum)
  • Maternal death
Management: Quinine is the first-line drug for severe falciparum malaria in pregnancy (artemisinin derivatives are used in second and third trimesters if quinine unavailable). Chloroquine for P. vivax. Intermittent preventive treatment (IPT) with sulfadoxine-pyrimethamine in endemic areas. Insecticide-treated bed nets.

Effects of Anaemia on Pregnancy Outcome

Maternal Effects

  • Increased incidence of pre-eclampsia (Dutta notes a higher association)
  • Cardiac failure (especially Hb < 5 g/dL) — "anaemic heart failure" or "hyper-dynamic circulatory failure"
  • Increased susceptibility to infections (puerperal sepsis, wound infection, UTI)
  • Impaired wound healing
  • Increased risk of postpartum haemorrhage (PPH) — the uterus of an anaemic patient contracts poorly; small blood losses are less well tolerated
  • Increased risk of requiring blood transfusion
  • Prolonged recovery; increased maternal mortality

Foetal and Neonatal Effects

  • Intrauterine growth restriction (IUGR) — foetal stores of iron depend on maternal levels
  • Preterm birth
  • Low birthweight
  • Increased perinatal mortality
  • Neonatal anaemia, especially in severe maternal IDA — neonatal iron stores are preferentially maintained at the expense of maternal stores in mild-moderate deficiency, but in very severe anaemia foetal iron stores are also depleted
  • Neural tube defects (folate deficiency)
Dutta emphasises that severe anaemia is an important indirect cause of maternal mortality in India, often acting synergistically with obstetric haemorrhage (the already-compromised circulatory reserve leaves no margin for further blood loss at delivery).

Management of Labour in Anaemic Patients

Both Dutta and Mudaliar & Menon provide specific guidance for conducting delivery in an anaemic patient:
  1. Blood should be cross-matched and available prior to delivery
  2. Active management of the third stage of labour (oxytocin 10 units IM after delivery of anterior shoulder) to minimise PPH
  3. Restrict episiotomy to absolute indications to prevent blood loss
  4. Avoid prolonged labour — monitor progress carefully; early recourse to instrumental delivery or caesarean if indicated
  5. Oxygen supplementation during labour
  6. Adequate pain relief — epidural reduces cardiorespiratory demand
  7. Prophylactic antibiotics — increased infection risk
  8. If emergency caesarean is required, regional anaesthesia (spinal/epidural) is preferable to general anaesthesia in the severely anaemic patient
  9. Postpartum: Continue iron therapy for at least 3 months; assess Hb at 6-week postnatal visit

Prevention of Anaemia in Pregnancy

Dutta outlines a comprehensive preventive strategy:
  1. Health education — dietary counselling emphasising iron-rich foods (red meat, green leafy vegetables, legumes) and vitamin C to enhance iron absorption
  2. Universal iron and folic acid supplementation — from first antenatal visit throughout pregnancy and 3 months postpartum
  3. Treatment of infections — deworming (single dose albendazole 400 mg after first trimester), malaria prophylaxis, UTI treatment
  4. Family planning — spacing of pregnancies; preventing grand multiparity
  5. Early booking — first antenatal visit before 12 weeks
  6. Screening — Hb estimation at booking, at 28 weeks, and at 36 weeks; peripheral smear and further work-up for Hb < 10 g/dL
Mudaliar & Menon add that national programmes in India (Anaemia Mukt Bharat, WIFS — Weekly Iron Folic Acid Supplementation for adolescent girls) address the root cause of anaemia in the community, recognising that the problem must be tackled before conception.

Aplastic Anaemia in Pregnancy

Aplastic anaemia in pregnancy is rare but carries a grave prognosis. Bone marrow failure results in pancytopenia. It may be idiopathic (most common), drug-induced, or viral (hepatitis, parvovirus B19). Management includes:
  • Blood and platelet transfusions
  • Antithymocyte globulin (ATG) and ciclosporin (after first trimester) — standard immunosuppression
  • Haematopoietic stem cell transplantation deferred until after delivery
  • High maternal and foetal mortality

Conclusion

Anaemia complicating pregnancy is a multifactorial condition with profound implications for maternal and perinatal health. Iron deficiency anaemia predominates, but megaloblastic, haemolytic, and aplastic forms each require distinct approaches. Dutta's textbook provides a clear clinically oriented framework for classification, grading, investigation, and management, with specific attention to the Indian context. Mudaliar & Menon emphasise the socioeconomic, nutritional, and infectious determinants peculiar to South Asia and the need for preventive strategies at both the individual and community level. A systematic approach — early detection, adequate supplementation, treatment of underlying causes, careful conduct of labour, and postpartum follow-up — is essential to reduce the burden of this preventable condition.
Key References:
  • DC Dutta's Textbook of Obstetrics, 10th Edition (ed. Hiralal Konar), Chapter on Anaemia in Pregnancy
  • Mudaliar & Menon's Clinical Obstetrics, 13th Edition, Chapter on Medical Disorders Complicating Pregnancy — Anaemia
  • Creasy & Resnik's Maternal-Fetal Medicine: Principles and Practice — Chapter 55: Anaemia in Pregnancy (laboratory reference ranges and haematologic changes)
  • Goldman-Cecil Medicine International Edition — Physiologic Anaemia of Pregnancy
This is a shared conversation. Sign in to Orris to start your own chat.